Royal DSM, a global science-based company active in health, nutrition and materials, today provides an update on the development of its Nutrition organization and several key positions to further support its growth plans.
In November 2015, DSM presented its Strategy 2018: Driving Profitable Growth. Key elements of the strategy for its Nutrition business are market-focused growth with global products and local solutions; continued innovation resulting in new ingredients, forms and custom-tailored premixes; expansion in new segments and geographies; as well as productivity improvements and cost reductions. As announced, the Nutrition strategy is designed to result in sales growth above the average market growth, with high single digit percentage EBITDA growth, an EBITDA margin of 18-20% and a high double digit basis point ROCE growth.
As part of the further execution of this strategy, DSM Nutritional Products has established a Global Products & Strategic Alliances Group under the leadership of André Bos, which includes product and category management as well as large, cross-industry business development programs. During 2015, under the leadership of Hans-Christian Ambjerg, the innovation efforts were further focused on a core number of technology and product/application platforms. Following a successful period of interim management by André Bos, the Human Nutrition & Health business will be led by Jeremy (Jinghuai) Xu, who recently joined from DuPont. DSM has also further strengthened the global sales organization at Human Nutrition & Health, especially in North America. The Animal Nutrition & Health business will be led by David Blakemore, who recently joined from Dow. David will build further on the great growth trajectory put in place by Mark Stock, who will be retiring in the autumn after an impressive 36-year career. The company’s ambitious growth plans for its Personal Care & Aroma Ingredients business will continue to be led by Wilfrid Gambade. In all three Nutritional Products businesses, DSM has developed a clear road map for further growth through global products, local solutions and strengthened customer management.
DSM Nutritional Products’ manufacturing and purchasing operations continue to be led by Luca Rosetto and remain focused on delivering important productivity improvements and cost reductions. Christian Nilsson joined the company from Tyco in the autumn of 2015, when he became the new CFO for DSM Nutritional Products, while Human Resources continues to be led by Jacoline van Blokland. Together with Philip Eykerman, DSM’s Executive Vice President Corporate Strategy, these key individuals are part of the Executive Leadership Team of DSM Nutritional Products, led by Chris Goppelsroeder, President and CEO of DSM Nutritional Products and also a member of the DSM Executive Committee.
DSM Food Specialties, active in bio-based ingredients such as enzymes, cultures, food preservation ingredients, and savory flavors, led by Ilona Haaijer, is executing its ambitious growth plans. The texturizing/hydrocolloids businesses, which are run from China, are also progressing well.
Feike Sijbesma, CEO Royal DSM said: “I am convinced that the Nutrition organization, under the leadership of DSM Board Member Stephan Tanda and DSM Nutritional Products President and CEO Chris Goppelsroeder, is well prepared to capture the attractive market growth opportunities for its businesses and to deliver on its communicated goals.”
Source: DSM
McCain Foods has completed the acquisition of Irish plant-based frozen food manufacturer Strong Roots. The acquisition follows McCain and Strong Roots’ strategic partnership, which began in 2021 and resulted from a $55 million investment.
Cargill partners with Voyage Foods to scale up alternatives to cocoa-based products to meet consumers’ indulgence needs. The commercial partnership will also provide food manufacturers with nut spreads produced with no nut or dairy allergens used in the recipe formulation.
L’Occitane International owner Reinold Geiger is reportedly close to taking the company private in a deal with Blackstone. The French skin care company’s filing halted trading of its Hong Kong-listed shares this week. This is the second time in months that the Australian billionaire has attempted a buyout.
